Chronic Leukemia — Trials

Chronic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,705 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 206
Ph III recruiting: 22
Growth YoY: −13.3%
Industry share: 28%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 1,201–1,250 of 1,705 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01203930	A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL	terminated	Phase 2	105	Gilead SciencesINDUSTRY	1	Nov 16, 2018	clinicaltrials
NCT00709592	Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT	completed	Phase 2	42	Virginia Commonwealth UniversityOTHER	1	Nov 9, 2018	clinicaltrials